The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and the CD20 antibbody was just also a straight naked antibbody straight naked antibbody targeted for an immune destruction it's targeted to destroy the CD20 positive cells but it turns out that if you have lymphoma you've got a reserve in your marrow of other CD20 cells of more um immature that grow up and replace
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.